Skip to content
10-Q

Quarterly Report

RENNOVA HEALTH, INC.

0001493152-23-017256

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 9, 2023 29.93B sh
Shares Diluted Q1 2023 · Mar 31, 2023 509.81B sh
Shares Diluted Q1 2023 · Mar 31, 2022 4.81M sh
Capex Q1 2023 · Mar 31, 2023 $220.45K
Operating Cash Flow Q1 2023 · Mar 31, 2023 $1.14M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$1.15M
Short Term Debt Q1 2023 · Mar 31, 2023 $8.32M
Short Term Debt Q1 2023 · Dec 31, 2022 $8.62M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $251.22K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $499.47K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$28.29M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$29.09M
Stockholders Equity Q1 2023 · Mar 31, 2022 −$28.57M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$27.3M
Current Liabilities Q1 2023 · Mar 31, 2023 $48.55M
Current Liabilities Q1 2023 · Dec 31, 2022 $49.31M
Total Liabilities Q1 2023 · Mar 31, 2023 $48.86M
Total Liabilities Q1 2023 · Dec 31, 2022 $49.67M
Current Assets Q1 2023 · Mar 31, 2023 $6.31M
Current Assets Q1 2023 · Dec 31, 2022 $6.36M
Total Assets Q1 2023 · Mar 31, 2023 $20.57M
Total Assets Q1 2023 · Dec 31, 2022 $20.57M
Eps Basic Q1 2023 · Mar 31, 2023 $0.00
Eps Basic Q1 2023 · Mar 31, 2022 −$28.71
Sga Expense Q1 2023 · Mar 31, 2023 $2.22M
Sga Expense Q1 2023 · Mar 31, 2022 $1.57M
Net Income Q1 2023 · Mar 31, 2023 $805.56K
Net Income Q1 2023 · Dec 31, 2022 −$3.3M
Net Income Q1 2023 · Mar 31, 2022 −$2.27M
Operating Income Q1 2023 · Mar 31, 2023 $752.05K
Operating Income Q1 2023 · Mar 31, 2022 −$1.92M
Revenue Q1 2023 · Mar 31, 2023 $4.92M
Revenue Q1 2023 · Mar 31, 2022 $1.14M